久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China approves first domestically produced nine-valent HPV vaccine

Xinhua | Updated: 2025-05-30 16:14
Share
Share - WeChat

XIAMEN -- China approved its first domestically developed nine-valent human papillomavirus (HPV) vaccine on Thursday, according to the National Medical Products Administration.

The vaccine, Cecolin 9, was jointly developed by the Xiang An Biomedicine Laboratory, Xiamen University and Wantai BioPharm. Its approval makes China the second country in the world — after the United States — with the capability to independently supply high-valency HPV vaccines.

Since 2019, the vaccine has been through five clinical trials conducted across China, involving more than 11,000 healthy volunteers aged nine to 45.

Results from these trials showed that the vaccine provides strong protection against HPV types 16 and 18 — the same strains covered by the two-valent vaccine — as well as five other HPV types 31, 33, 45, 52 and 58, with a protection rate of over 98 percent against persistent infections lasting more than 12 months and a 100 percent protection rate against cervical infections.

For girls aged nine to 17, just two doses are sufficient to produce an immune response comparable to that seen in women aged 18 to 26 who receive three doses. For girls aged 15 to 17, it is currently the only two-dose HPV vaccine available in China.

A comparative study showed that the new vaccine offers immune responses comparable with similar international products for at least 30 months after full immunization. These findings have been published in The Lancet Infectious Diseases.

The new vaccine is the latest achievement from the research team that also developed China's first domestically made two-valent HPV vaccine in 2019. In 2021, the two-valent HPV vaccine received prequalification from the World Health Organization (WHO) and has since entered the markets of 21 countries.

Cervical cancer was the fourth most common cancer among women worldwide in 2022, according to the WHO. China made free HPV vaccination accessible to approximately 40 percent of girls aged 13 to 14 in 2024, as part of its ongoing work to tackle cervical cancer, according to the National Health Commission.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美日韩国产一区二区三区播放 | 私人玩物福利 | 日本黄网站高清色大全 | 久久久久久88色愉愉 | 久爱综合| 中文字幕中文字幕在线 | 青青青青爽视频在线播放 | 久久毛片免费 | 日本黄色免费大片 | 久草中文视频 | 国产一级毛片亚洲久留木玲 | 亚洲天堂网在线视频 | 欧美一级成人毛片影院 | 国产无毛| 亚洲视频中文字幕在线观看 | 国产成人精品区在线观看 | 亚洲欧美二区三区久本道 | 国产成人免费视频精品一区二区 | 一区二区三区免费视频观看 | 欧美日韩一区二区综合 | www国产 | 美国毛片一级视频在线aa | 亚洲精品tv久久久久 | 黄色网址进入 | 在线黄色影院 | 一区二区三区在线免费看 | 国产一区二区亚洲精品天堂 | 免费观看欧美一级毛片 | 中文字幕欧美一区 | 草久免费视频 | 国产的一级毛片完整 | av毛片免费看 | 国产成人在线综合 | 日本一区二区三区在线 视频观看免费 | 成年人免费毛片 | 免费国产成人高清在线观看不卡 | 国产激情一区二区三区 | 91日韩精品天海翼在线观看 | 欧美日韩国产人成在线观看 | 在线不卡一区 | 国产日韩欧美另类 |